Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Assessment of diabetic nephropathy in the Akita mouse.

Chang JH, Gurley SB.

Methods Mol Biol. 2012;933:17-29. doi: 10.1007/978-1-62703-068-7_2.

PMID:
22893398
2.

Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.

Gurley SB, Mach CL, Stegbauer J, Yang J, Snow KP, Hu A, Meyer TW, Coffman TM.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F788-95. doi: 10.1152/ajprenal.90515.2008. Epub 2009 Dec 30.

3.

A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.

Tchekneva EE, Rinchik EM, Polosukhina D, Davis LS, Kadkina V, Mohamed Y, Dunn SR, Sharma K, Qi Z, Fogo AB, Breyer MD.

J Am Soc Nephrol. 2007 Jan;18(1):103-12. Epub 2006 Dec 6.

4.

Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.

Yu L, Su Y, Paueksakon P, Cheng H, Chen X, Wang H, Harris RC, Zent R, Pozzi A.

Kidney Int. 2012 Jun;81(11):1086-97. doi: 10.1038/ki.2011.474. Epub 2012 Feb 1.

5.

The Ins2Akita mouse as a model of early retinal complications in diabetes.

Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2210-8.

PMID:
15914643
6.

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.

Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW.

Am J Pathol. 2007 Aug;171(2):438-51. Epub 2007 Jun 28.

7.

Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.

Nasrallah R, Robertson SJ, Hébert RL.

Am J Nephrol. 2009;30(4):346-53. doi: 10.1159/000229304. Epub 2009 Jul 17.

PMID:
19609076
8.

High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.

Yang XQ, Chen AF.

Clin Exp Pharmacol Physiol. 2009 Aug;36(8):764-9. doi: 10.1111/j.1440-1681.2009.05145.x. Epub 2009 Jan 17.

PMID:
19207718
9.

Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.

Shi Y, Lo CS, Chenier I, Maachi H, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

Am J Physiol Renal Physiol. 2013 Jun 1;304(11):F1335-46. doi: 10.1152/ajprenal.00405.2012. Epub 2013 Apr 3.

10.

Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.

Liu GC, Fang F, Zhou J, Koulajian K, Yang S, Lam L, Reich HN, John R, Herzenberg AM, Giacca A, Oudit GY, Scholey JW.

Diabetologia. 2012 Sep;55(9):2522-32. doi: 10.1007/s00125-012-2586-1. Epub 2012 Jun 1.

PMID:
22653270
11.

Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.

Nasrallah R, Xiong H, Hébert RL.

Am J Physiol Renal Physiol. 2007 Jan;292(1):F278-84. Epub 2006 Sep 5.

12.

Arginase-2 mediates diabetic renal injury.

Morris SM Jr, Gao T, Cooper TK, Kepka-Lenhart D, Awad AS.

Diabetes. 2011 Nov;60(11):3015-22. doi: 10.2337/db11-0901. Epub 2011 Sep 16.

13.

Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse.

Haseyama T, Fujita T, Hirasawa F, Tsukada M, Wakui H, Komatsuda A, Ohtani H, Miura AB, Imai H, Koizumi A.

Tohoku J Exp Med. 2002 Dec;198(4):233-44.

14.

Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion.

Chang JH, Paik SY, Mao L, Eisner W, Flannery PJ, Wang L, Tang Y, Mattocks N, Hadjadj S, Goujon JM, Ruiz P, Gurley SB, Spurney RF.

PLoS One. 2012;7(4):e33942. doi: 10.1371/journal.pone.0033942. Epub 2012 Apr 4.

15.

Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.

Lo CS, Shi Y, Chang SY, Abdo S, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

Diabetologia. 2015 Oct;58(10):2443-54. doi: 10.1007/s00125-015-3700-y. Epub 2015 Aug 1.

16.

Late-intervention study with ebselen in an experimental model of type 1 diabetic nephropathy.

Tan SM, Sharma A, Stefanovic N, de Haan JB.

Free Radic Res. 2015 Mar;49(3):219-27. doi: 10.3109/10715762.2014.993628. Epub 2015 Jan 30.

PMID:
25465090
17.
18.
19.

Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.

de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH.

Am J Physiol Renal Physiol. 2005 Sep;289(3):F544-51. Epub 2005 Apr 12.

20.

Diabetic nephropathy: of mice and men.

Breyer MD, Böttinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K.

Adv Chronic Kidney Dis. 2005 Apr;12(2):128-45. Review.

PMID:
15822049

Supplemental Content

Support Center